10-Q: Mitesco Reports Q2 Net Income Amid Restructuring

Mitesco, Inc. reported a net income for Q2 2025 driven by non-operating gains from debt restructuring and derivative revaluation, despite ongoing operational losses and significant going concern doubts.

Summary

• Mitesco, Inc. is a holding company focused on datacenter services (Centcore, LLC) and AI/cloud computing investments (Vero Technology Ventures, LLC), having ceased its former clinic operations.
• For the six months ended June 30, 2025, the company reported a net income of $3,362,952, a significant improvement from a net loss of $365,921 in the prior year period.
• This net income was primarily driven by a $4,430,867 gain on revaluation of derivative liabilities and a $562,793 gain on forgiveness of liabilities.
• Revenue increased to $35,700 for the six months ended June 30, 2025, up from $6,000 in the comparable 2024 period, attributed to the new Centcore subsidiary.
• Operating expenses rose to $654,440 for the six months ended June 30, 2025, compared to $481,353 in the prior year, due to establishing new operations and software development.
• The company continues to face substantial doubt about its ability to continue as a going concern, with cash and cash equivalents of only $2,724 as of June 30, 2025, and approximately $2,000 as of August 13, 2025.
• Current liabilities stood at $15.9 million as of June 30, 2025, down from $18.4 million at December 31, 2024, largely due to debt restructuring efforts.
• The company converted over $25 million in obligations from its discontinued clinic operations into 2,478,179 shares of restricted Common Stock and 566,085 shares of Series A Preferred Stock.
• Legal settlements related to former clinic leases total $2,764,215 as of June 30, 2025, with a subsequent additional judgment of $500,000 for the Quincy Clinic property as of August 8, 2025.
• Material weaknesses in disclosure controls and procedures were identified, including a lack of segregation of duties and insufficient resources.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to severe going concern risk, critically low cash, persistent operating losses, and identified material weaknesses in internal controls. While debt restructuring and non-operating gains provided a temporary accounting positive, they do not address the fundamental operational and liquidity challenges. The new business ventures are nascent and not yet self-sustaining.

Positives

• Reported a net income of $3,362,952 for the six months ended June 30, 2025, primarily due to non-operating gains.
• Successfully restructured over $25 million in debt and senior securities, reducing total liabilities from $26.6 million to $22.2 million.
• Revenue increased significantly to $35,700 for the six months ended June 30, 2025, from $6,000 in the prior year, indicating initial traction in new business segments.
• Formed new business units, Centcore (datacenter services) and Vero Technology Ventures (AI/cloud computing investments), signaling a strategic pivot.
• Established an Advisory Board with experienced professionals in relevant technology and cybersecurity fields.

Negatives

• Faces substantial doubt about its ability to continue as a going concern due to recurring operating losses and insufficient cash.
• Cash and cash equivalents are extremely low at $2,724 as of June 30, 2025, and further decreased to approximately $2,000 by August 13, 2025.
• Incurred increased operating expenses of $654,440 for the six months ended June 30, 2025, up from $481,353 in the prior year.
• Net loss from operations increased to $(618,740) for the six months ended June 30, 2025, from $(475,353) in the prior year, indicating continued operational unprofitability.
• Diluted net income per common share remains negative at $(0.07) for the six months ended June 30, 2025.
• Ongoing legal proceedings and settlements from the discontinued clinic operations continue to be a financial burden, with an additional $500,000 judgment for the Quincy Clinic.
• The Kishon Note, with principal and interest totaling $637,020, remains in default with intermittent communication from the holder.
• Identified material weaknesses in disclosure controls and procedures, including lack of segregation of duties and insufficient resources.

Risks

• Substantial doubt about the ability to continue as a going concern due to recurring losses and negative cash flows.
• Dependence on raising additional capital and generating sufficient revenues to sustain operations, with no formal capital raising agreement in place.
• Exposure to legal proceedings and liabilities from the winding down of former clinic operations, including potential for further judgments or settlements.
• Risks associated with the new business ventures (datacenter services, AI development) including market acceptance, competition, and successful execution.
• Material weaknesses in internal controls over financial reporting and disclosure controls, which could lead to financial misstatements or non-compliance.
• High dilution risk for common shareholders due to preferred stock conversions and dividends paid in common stock, as well as potential future equity raises.
• The variable conversion prices of certain convertible notes and preferred stock could lead to significant dilution if the stock price declines.

Future Outlook

The company is actively developing its 'Robo Agent' AI-based sales automation tool, expected to be available for initial users in Q3 FY2025, with later versions targeting other B2C markets. It anticipates continued use of consultants to control costs rather than building a large internal employment force. The company intends to register shares of Common Stock issued and to be issued to Series A Preferred Stockholders. It also plans to cancel all outstanding warrants.

Management Comments

• Our continuance is dependent on raising capital and generating revenues sufficient to sustain operations.
• We continue to attempt to resolve the Kishon Note though communication with the holder has been intermittent at best.
• We believe that there is no further obligation in the administrative office lease situation, but we do not have such documented in writing at this time.
• We have retained experienced professionals in the datacenter, cyber security and infrastructure services areas to support our needs on a per hour basis, which we believe will allow us to control our costs relative to business activity, without significant staffing internally.

Industry Context

Mitesco's strategic pivot into datacenter services and AI-based applications aligns with broader industry trends towards cloud computing, digital transformation, and the increasing adoption of artificial intelligence across various sectors. The focus on managed services and hosting software for vendors positions Centcore to capitalize on the growing demand for scalable and flexible IT infrastructure. Vero Technology Ventures' development of an AI-powered sales tool for residential real estate taps into the proptech and D2C automation markets, reflecting a trend towards leveraging AI for enhanced efficiency and targeted marketing. However, the company operates in highly competitive and capital-intensive markets, requiring significant investment and rapid innovation to gain market share against established players.

Corporate Governance

Legal Proceedings

• Ongoing legal situations related to the winding down of former clinic business activities, including claims regarding construction contracts and lease cancellations.
• Egan Clinic: Summary Judgment granted on December 4, 2023, for $488,491, with final judgment entered December 15, 2023. Total settlement obligation of $564,910 including interest.
• St. Paul Clinic: Stipulation for Judgment filed December 21, 2023, for $415,266, with final judgment entered January 19, 2024. Total settlement obligation of $475,385 including interest.
• St. Louis Park Clinic: Confession of Judgment executed April 2, 2024, for $425,350. Total settlement obligation of $472,430 including interest.
• Maple Grove Clinic: Settlement agreement entered October 22, 2022, for $219,576. Total settlement obligation of $279,060 including interest.
• Radiant Clinic: Settled amounts owed for approximately $530,000 as of April 10, 2024.
• Quincy Clinic: Final Judgment granted November 14, 2023, for $348,764. Subsequent litigation settled August 8, 2025, with an additional judgment of $500,000, bringing the total settlement obligation to $416,873 (original judgment) plus the additional $500,000.
• Nordhaus Clinic: Lease terminated November 6, 2023; company believes no additional amounts are owed.
• Administrative office lease: Abandoned, company believes no further obligations exist, but not formally documented.
• Gardner Debt for Equity Agreement: Company is continuing efforts to negotiate a settlement for amounts claimed by Gardner Builders Holdings, LLC.

Related Party Transactions

• Acquisition of AgingTopic, LLC: The entity owning the business and source code is controlled by Ms. Amy Lance, wife of Mack Leath (CEO/CFO). The agreement includes a $5,000 cash payment and royalty payments up to $150,000.
• Settlement of Finnegan Notes (Jessica Finnegan and family) and Lindstrom Notes (Jenny Lindstrom, former Chief Legal Officer): These related party notes and accrued interest were settled by issuing 75,000 shares of restricted common stock to each holder, resulting in an aggregate gain on settlement of liabilities of $553,403.

Stakeholder Impact

• Shareholders: Face significant dilution from preferred stock conversions and dividends paid in common stock, as well as potential future capital raises. The going concern risk poses a substantial threat to investment value.
• Creditors: Some creditors (Finnegan, Lindstrom) have had their obligations settled through equity, while others (Kishon) remain in default. Legal settlements for former clinic leases continue to be a factor.
• Employees/Consultants: The company relies on consultants on a per-hour basis to control costs, indicating a lean internal workforce structure.
• Customers: New customers for Centcore's datacenter services and VTV's AI applications are critical for future revenue generation and operational sustainability.

Next Steps

• Continue development and initial user availability of the 'Robo Agent' AI application in Q3 FY2025.
• Seek to create similar co-location situations with other datacenters worldwide based on client needs for Centcore.
• Continue efforts to negotiate a settlement for the Gardner Debt for Equity Agreement.
• Take corrective action to address identified material weaknesses in disclosure controls and procedures.
• Register shares of Common Stock issued and to be issued to Series A Preferred Stockholders.
• Cancel all outstanding warrants.

Key Dates

Recommendation

The company faces severe going concern risk with critically low cash reserves and persistent negative cash flow from operations. While the reported net income is positive, it is an accounting artifact driven by non-recurring gains from debt restructuring and derivative revaluation, not sustainable operational profitability. The underlying business remains highly unprofitable, and the new ventures are nascent. Significant liabilities from past operations and material weaknesses in internal controls further compound the risk. Without a clear path to substantial, sustained revenue generation and a significant capital infusion, the company's ability to continue operations is highly questionable, making the stock a high-risk investment with substantial downside potential.

Keywords

Datacenter Services, Cloud Computing, Artificial Intelligence, AI, Robo Agent, SEC Filing, 10-Q, Financial Restructuring, Going Concern, Debt Settlement, Corporate Governance, Technology Infrastructure, Managed Services